Reviews in Signaling Modulation by Natural and Synthetic Agents in Cancer
This special issue belongs to the section "Cancer Biology".
Special Issue Information
Dear Colleagues,
Cellular signaling pathways govern critical processes such as cell proliferation, differentiation, apoptosis, and immune surveillance. In cancer, dysregulation of these pathways drives oncogenesis, tumor progression, metastasis, and resistance to conventional therapies. Targeting aberrant signaling networks has therefore emerged as a cornerstone of modern oncology.
This Special Issue aims to collect high-quality review articles that provide an overview of the current landscape and future perspectives of cancer therapeutics. We welcome comprehensive reviews focusing on how both natural compounds and synthetic agents modulate oncogenic signaling pathways.
Topics of interest include, but are not limited to, the molecular mechanisms of action of these agents, their impact on tumor progression and modulation of the tumor microenvironment, the overcoming of multidrug resistance, and the synergy between natural and synthetic molecules. By bringing together up-to-date literature and critical insights, this Special Issue aims to provide a comprehensive roadmap for developing novel, more effective, and safer anticancer strategies.
Dr. Federica Finetti
Dr. Lorenza Trabalzini
Guest Editors
Dr. Clizia Bernardi
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biology is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer signaling pathways
- target therapy
- natural products
- synthetic anticancer agents
- molecular mechanisms
- apoptosis induction
- tumor microenvironment
- drug resistance
- phytochemicals
- combination therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

